MedTrace Logo

Oral Supplementation With Active Collagen Peptides and Skin Health Improvement

NCT06321770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-07-11

No results posted yet for this study

Summary

The present study aims to investigate the efficacy of daily supplementation with COLLinstant® LMW over a 6-week period in improving visible signs of aging. This in-cludes assessing its impact on skin wrinkle reduction, as well as its potential to en-hance skin elasticity and moisturization. COLLinstant® LMW was administered orally in a single-center, randomized, double-blind, placebo-controlled clinical trial. A sec-ondary objective involves comparing skin improvement, product satisfaction, and monitoring adverse events among middle-aged female volunteers.

Conditions

  • Facial Wrinkles
  • Skin Hydration

Interventions

DIETARY_SUPPLEMENT

Bioactive collagen peptides

2,5 g collagen peptides

DIETARY_SUPPLEMENT

Placebo

Placebo sachet daily

Sponsors & Collaborators

  • Gala Servicios Clinicos S.L.

    lead OTHER

Principal Investigators

  • Juan Antonio Carrillo · University of Extremadura

  • Rafael Guerrero · University of Extremadura

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-04-16
Completion
2024-06-03

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06321770 on ClinicalTrials.gov